Todos Med Ltd (TOMDF)

[arpemd]

Thanks JFB, good article and discussion. Note this line:

If we learned anything from CytoDyn’s mishaps, it was that even 309 patients isn’t necessarily enough for an EUA.

and this one (which speaks of reg capture to me, considering the very sketchy approval of remdesivir): "The GILD, HGEN, TOMDF, and CYDY mortality data reconciles to real world conditions. The only thing that doesn’t make sense is: why the regulatory process wasn’t accelerated for any of the drugs besides Gilead’s on the announcement of such good data during a pandemic."